Improving timely treatment for cervical cancer in Botswana
Thibang Diphatlha: Testing adaptive strategies to close the gap from cervical cancer diagnosis to treatment in Botswana
This study is looking for better ways to help women in Botswana, especially those living with HIV, get faster treatment for cervical cancer after they are diagnosed, so they can receive the care they need more quickly.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10906756 on NIH RePORTER |
What this research studies
This research investigates ways to reduce delays in cervical cancer treatment in Botswana, particularly for women living with HIV. It aims to identify and test adaptive strategies that can facilitate quicker access to care after diagnosis. By employing a Sequential Multiple Assignment Randomized Trial (SMART) design, the study will evaluate how different approaches can effectively address barriers to timely treatment. The research focuses on understanding the individual and systemic factors that contribute to these delays, with the goal of improving health outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are women in Botswana who have been diagnosed with cervical cancer, particularly those living with HIV.
Not a fit: Patients who have already received timely treatment for cervical cancer or those not residing in Botswana may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more effective treatment for cervical cancer, significantly reducing mortality rates in affected populations.
How similar studies have performed: Previous research has shown that targeted interventions can improve treatment timelines in similar contexts, suggesting that this approach may yield positive results.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Grover, Surbhi — University of Pennsylvania
- Study coordinator: Grover, Surbhi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.